Adaptive propensity score procedure improves matching in prospective observational trials
Abstract Background Randomized controlled trials are the gold-standard for clinical trials. However, randomization is not always feasible. In this article we propose a prospective and adaptive matched case-control trial design assuming that a control group already exists. Methods We propose and disc...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12874-019-0763-3 |
id |
doaj-f43a4b93418d4d87b13971cda5d4c926 |
---|---|
record_format |
Article |
spelling |
doaj-f43a4b93418d4d87b13971cda5d4c9262020-11-25T03:20:52ZengBMCBMC Medical Research Methodology1471-22882019-07-0119111110.1186/s12874-019-0763-3Adaptive propensity score procedure improves matching in prospective observational trialsDorothea Weber0Lorenz Uhlmann1Silvia Schönenberger2Meinhard Kieser3Institute of Medical Biometry and Informatics, University of HeidelbergInstitute of Medical Biometry and Informatics, University of HeidelbergDepartment of Neurology, Heidelberg University HospitalInstitute of Medical Biometry and Informatics, University of HeidelbergAbstract Background Randomized controlled trials are the gold-standard for clinical trials. However, randomization is not always feasible. In this article we propose a prospective and adaptive matched case-control trial design assuming that a control group already exists. Methods We propose and discuss an interim analysis step to estimate the matching rate using a resampling step followed by a sample size recalculation. The sample size recalculation is based on the observed mean resampling matching rate. We applied our approach in a simulation study and to a real data set to evaluate the characteristics of the proposed design and to compare the results to a naive approach. Results The proposed design achieves at least 10% higher matching rate than the naive approach at final analysis, thus providing a better estimation of the true matching rate. A good choice for the interim analysis seems to be a fraction of around 12 $\frac {1}{2}$ to 23 $\frac {2}{3}$ of the control patients. Conclusion The proposed resampling step in a prospective matched case-control trial design leads to an improved estimate of the final matching rate and, thus, to a gain in power of the approach due to sensible sample size recalculation.http://link.springer.com/article/10.1186/s12874-019-0763-3Adaptive designClinical TrialsSample size recalculationMatched cohortProspective matching |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dorothea Weber Lorenz Uhlmann Silvia Schönenberger Meinhard Kieser |
spellingShingle |
Dorothea Weber Lorenz Uhlmann Silvia Schönenberger Meinhard Kieser Adaptive propensity score procedure improves matching in prospective observational trials BMC Medical Research Methodology Adaptive design Clinical Trials Sample size recalculation Matched cohort Prospective matching |
author_facet |
Dorothea Weber Lorenz Uhlmann Silvia Schönenberger Meinhard Kieser |
author_sort |
Dorothea Weber |
title |
Adaptive propensity score procedure improves matching in prospective observational trials |
title_short |
Adaptive propensity score procedure improves matching in prospective observational trials |
title_full |
Adaptive propensity score procedure improves matching in prospective observational trials |
title_fullStr |
Adaptive propensity score procedure improves matching in prospective observational trials |
title_full_unstemmed |
Adaptive propensity score procedure improves matching in prospective observational trials |
title_sort |
adaptive propensity score procedure improves matching in prospective observational trials |
publisher |
BMC |
series |
BMC Medical Research Methodology |
issn |
1471-2288 |
publishDate |
2019-07-01 |
description |
Abstract Background Randomized controlled trials are the gold-standard for clinical trials. However, randomization is not always feasible. In this article we propose a prospective and adaptive matched case-control trial design assuming that a control group already exists. Methods We propose and discuss an interim analysis step to estimate the matching rate using a resampling step followed by a sample size recalculation. The sample size recalculation is based on the observed mean resampling matching rate. We applied our approach in a simulation study and to a real data set to evaluate the characteristics of the proposed design and to compare the results to a naive approach. Results The proposed design achieves at least 10% higher matching rate than the naive approach at final analysis, thus providing a better estimation of the true matching rate. A good choice for the interim analysis seems to be a fraction of around 12 $\frac {1}{2}$ to 23 $\frac {2}{3}$ of the control patients. Conclusion The proposed resampling step in a prospective matched case-control trial design leads to an improved estimate of the final matching rate and, thus, to a gain in power of the approach due to sensible sample size recalculation. |
topic |
Adaptive design Clinical Trials Sample size recalculation Matched cohort Prospective matching |
url |
http://link.springer.com/article/10.1186/s12874-019-0763-3 |
work_keys_str_mv |
AT dorotheaweber adaptivepropensityscoreprocedureimprovesmatchinginprospectiveobservationaltrials AT lorenzuhlmann adaptivepropensityscoreprocedureimprovesmatchinginprospectiveobservationaltrials AT silviaschonenberger adaptivepropensityscoreprocedureimprovesmatchinginprospectiveobservationaltrials AT meinhardkieser adaptivepropensityscoreprocedureimprovesmatchinginprospectiveobservationaltrials |
_version_ |
1724616030355980288 |